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Abstract
Rabbit Hemorrhagic disease virus (RHDV), a calicivirus of the Lagovirus genus, and responsible for rabbit hemorrhagic
disease (RHD), kills rabbits between 48 to 72 hours post infection with mortality rates as high as 50–90%. Caliciviruses,
including noroviruses and RHDV, have been shown to bind histo-blood group antigens (HBGA) and human non-secretor
individuals lacking ABH antigens in epithelia have been found to be resistant to norovirus infection. RHDV virus-like particles
have previously been shown to bind the H type 2 and A antigens. In this study we present a comprehensive assessment of
the strain-specific binding patterns of different RHDV isolates to HBGAs. We characterized the HBGA expression in the
duodenum of wild and domestic rabbits by mass spectrometry and relative quantification of A, B and H type 2 expression. A
detailed binding analysis of a range of RHDV strains, to synthetic sugars and human red blood cells, as well as to rabbit
duodenum, a likely gastrointestinal site for viral entrance was performed. Enzymatic cleavage of HBGA epitopes confirmed
binding specificity. Binding was observed to blood group B, A and H type 2 epitopes in a strain-dependent manner with
slight differences in specificity for A, B or H epitopes allowing RHDV strains to preferentially recognize different subgroups
of animals. Strains related to the earliest described RHDV outbreak were not able to bind A, whereas all other genotypes
have acquired A binding. In an experimental infection study, rabbits lacking the correct HBGA ligands were resistant to
lethal RHDV infection at low challenge doses. Similarly, survivors of outbreaks in wild populations showed increased
frequency of weak binding phenotypes, indicating selection for host resistance depending on the strain circulating in the
population. HBGAs thus act as attachment factors facilitating infection, while their polymorphism of expression could
contribute to generate genetic resistance to RHDV at the population level.
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Introduction
Rabbit hemorrhagic disease virus (RHDV), a single stranded
positive-sense RNA virus belonging to the Lagovirus genus of the
Caliciviridae family, is the cause of rabbit hemorrhagic disease
(RHD), a disease affecting wild and domestic rabbits of the
Oryctolagus cuniculus species. RHD was first described in Angora
rabbits in China in 1984. By 1987 RHD was detected in
Czechoslovakia and Italy, and rapidly expanded to most European
countries [1]. RHDV usually kills rabbits within 48 to 72 hours of
infection. The disease is characterized by acute necrotizing
hepatitis and haemorrhages, sometimes preceded by tracheitis
and generally associated with disseminated intravascular coagula-
tion in many organs, particularly the lungs, heart and kidneys.
There are three different clinical courses of RHD, the peracute
form is distinguished by sudden death with no previous clinical
signs. The acute form of RHD involves depression, anorexia,
apathy, rapid respiration, anemia and some animals show signs of
abdominal distress. Animals perish after one to three days. The
sub acute form involves slight clinical symptoms and the animals
recover within 2–3 days [2,3]. Mortality rates are as high as 50–
90% although rates are lower in young animals less than 6–8
weeks-old, and no mortality occurs in animals less than 4 weeks-
old. Kittens can become infected and shed virus but do not show
clinical signs of the disease. The most common routes of infection
are the oral and upper respiratory routes, mainly through direct
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contaminated food. The virus is present in the blood, organs,
secretions and skin or fur of infected animals. It is excreted in large
amounts through urine and feces and can also be spread by insects
[4]. In addition RHDV is resistant in the environment particularly
in dry conditions and to date there is no evidence that RHDV can
infect other species [5]. RHDV has become endemic in the
original distribution range of the rabbit, Spain, Portugal and
France, where it has caused severe long term decline of rabbit
population size [6,7]. The drastic decline also threatens species
dependent on rabbits such as the Iberian lynx (Lynx pardinus) and
the Spanish imperial eagle (Aquila adalberti), which are specialist
predators, and to a lesser extent the Bonelli eagle (Hieraaetus
fasciatus). The decline of wild rabbit populations has also had an
impact on lizard populations, which use rabbit warrens during hot
summer periods [8]. In addition, RHDV can cause devastating
losses for rabbit producers, although efficient vaccines are
commercially available allowing protection of farmed rabbits [9].
Anti-RHDV antibodies have been detected in wild rabbit serum
sampled prior to the reported emergence of RHDV [10]. This has
led to speculation that non-pathogenic RHDV strains may have
been circulating in rabbit populations prior to the first detected
RHDV outbreak. Such strains were indeed discovered later in
countries such as Italy, France and Australia [11,12,13,14].
Infection by these non-pathogenic strains has been reported to
confer complete protection [11], partial protection [15] or no
protection [12,16] against RHDV in rabbits through cross-
recognizing antibodies.
The genetic diversity between RHDV isolates is quite low even
between isolates that are not geographically correlated. Indeed,
the nucleotide and amino acid differences between strains range
between 1–10% and 1–6%, respectively, which is far lower than
the differences observed for other caliciviruses [12,16]. Neverthe-
less, it has been suggested that French RHDV isolates can be
assigned into six genetic groups, G1 to G6 following spatio-
temporal distribution [17]. In France, G1 has almost completely
disappeared and is found exclusively in the south-west near the
Spanish border. G2, in which had been included the strain isolated
in the first reported outbreak in China in 1984, has not been
isolated recently. The genetic group G4 emerged from G3, while
G5 and G6 appeared as new independent groups [17], the latter
corresponding to the first antigenic variant identified, RHDVa
[18]. More recently, the pathogenic forms of RHDV were shown
to cluster into four major groups [19,20] with the genetic groups
G3, G4 and G5 as an artificial subdivision of Group 4 identified by
Kerr and co-workers, which clusters Western Europe and Bahrain
strains collected from 1989 onward. RHDV has previously been
shown to bind the oligosaccharide H type 2 and A type 2 (Fig 1A),
histo-blood group antigens (HBGAs) expressed on the duodenal
surface and trachea of rabbits, two possible doors of entry for the
virus [21]. HBGAs are polymorphic carbohydrate structures
representing terminal exposed portions of larger glycans O- or N-
linked to proteins or to glycolipids. In many vertebrate species they
are mainly expressed on epithelial cells and only a few primate
species, including humans, express them on vascular endothelial
cells and erythrocytes. They are synthesized by stepwise addition
of monosaccharide units from several precursors by specific
glycosyltransferases (Fig. 1). The recent occurrence of the highly
pathogenic RHDV with a documented HBGA binding ability can
be expected to provide a useful model to study the impact of the
virus on the host’s HBGA diversity and reciprocally of the host
diversity on the virus HBGA-binding properties. We have here
determined host diversity regarding HBGA expression on the
duodenum surface, a likely point of entry for the virus, and strain-
specific binding of RHDV by examining the binding to synthetic
sugars, haemagglutination and binding to the duodenal mucosa of
both wild and domestic rabbits. The role of each glycan for
binding was determined through specific enzymatic removal of the
monosaccharide comprising the A, B or H epitopes. Host variation
was determined through semi-quantitative A, B and H phenotyp-
ing of rabbit duodenums and structural characterization of glycans
by mass spectrometry. The role of HBGA binding in RHDV
Figure 1. Schematic of the synthesis of rabbit HBGA ligands. (A)
Schematic of the synthesis of H type 2, A type 2, B type 2 and Le
y. (B)
Structural representation of H type 1, H type 2 and H type 3. (C)
Structural representation of core structures of O-glycans. The symbol
presentation of O-glycans is based on the nomenclature used in
Essentials of Glycobiology textbook (http://www.ncbi.nlm.nih.gov/
books/NBK1908) and adopted by the Consortium for Functional
Glycomics (http://www.functionalglycomics.org).
doi:10.1371/journal.ppat.1002188.g001
Author Summary
Rabbit hemorrhagic disease virus (RHDV), detected as late
as 1984, has spread to large parts of the world, threatening
rabbit populations and other species dependent on
rabbits in many European countries. Mortality has been
shown to be as high as 90% and rabbits are killed 48 to
72 hours after infection. Related viruses called noroviruses,
infect humans in a manner dependent on the expression
of histo-blood group antigens (HBGAs), which are not only
expressed on red blood cells, but also on epithelial cells, in
saliva and on mucins of the intestinal tract. RHDV also
binds to HBGA and in this report we characterize binding
of strains of all genetic groups of RHDV to different HBGAs.
We also demonstrate HBGAs to function as attachment
factors in a challenge experiment. As polymorphisms of
genes involved in HBGA synthesis divide the rabbit
population into different subgroups, we find selection of
low-binding subgroups of wild rabbits in populations
recovering from devastating outbreaks of RHDV. This is the
first demonstration of differential HBGA specificities of
RHDV strains, description of function in infection and
demonstration of host selection due to RHDV infection
based on HBGA phenotype.
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positive rabbits with a strain largely dependent on AB binding,
revealing an important role of HBGA binding at lower dose
infections. In addition, preliminary evidence for selection of weak-
binding ABH phenotypes were detected in wild rabbit populations
following RHDV outbreaks. Understanding the selection of weak-
binding RHDV phenotypes is important as resistance to infection
generates problems for controlling the large rabbit population in
Australia and provides possibilities of selecting RHDV resistant
animals in areas where the rabbit populations are threatened.
Results
Phylogenetic relationships between the strains used
The strains used in this study were chosen to represent each of
the six chronologically established genetic groups (G1–G6)
previously identified by Le Gall-Recule ´ and co-workers [17]. To
analyze the phylogenetic position of these strains, a neighbor-
joining tree was constructed using complete nucleotide sequences
of the capsid gene. Similar to the finding of Kerr et al. [20], the
resulting phylogenetic diagram shows a division of the analyzed
strains into four rather than six clades with G3, G4 and G5
forming a major group while G1, G2 and G6 are clearly distinct
highly supported groups (Fig 2). G1 corresponds to strains that
circulated in Western Europe during the first RHDV outbreaks
[17] and now exclusively circulate in the Iberian Peninsula and
sporadically in the South of France [19,22]. G6 corresponds to the
antigenic variant strains (RHDVa) first described by Capucci et al
[18].
Binding of RHDV strains to synthetic sugars
To address the question of carbohydrate binding of RHDV, six
different strains designated G1–G6 were used. RHDV liver
extracts with high virus titres, at least 1610
10 viral RNA copies,
were used to screen a panel of 38 polyacrylamide (PAA)-
conjugated oligosaccharides and 19 human serum albumin
(HSA)- conjugated oligosaccharides (see Table S1). The carbohy-
drates with any capacity to bind RHDV were then used to
determine binding over a range of RHDV dilutions (Fig 3). The
dilution corresponding to equivalent amounts of viral RNA,
determined through real time RT-PCR, are shown in the figure
with a vertical line. The antigenic variant G6 was detected with a
mouse monoclonal antibody 2G3 previously determined to bind
G6 strains as well as all other pathogenic RHDV strains (kindly
provided by Lorenzo Capucci). G1–G5 were on the other hand
detected with a high-titered anti-RHDV rabbit serum and the
amount of G6 may therefore not be completely comparable to that
of the other strains. All strains showed strongest binding to B type
2. G1 was the only strain showing strong binding to Le
y and the
binding to H type 2, A type 2 and B trisaccharide varied between
the strains tested. Therefore H type 2 is not the only HBGA which
may be of relevance for RHDV binding and individual strains
show distinct specificities for synthetic oligosaccharides.
Haemagglutination characteristics of RHDV strains
Human red blood cells (RBC) carry A, B and H type 2 on their
surface, all of which may be ligands of the G1–G6 strains tested on
synthetic sugars. Therefore the ABH expression in this non-
synthetic system was used to test for RHDV strain binding.
Moreover, RHDV strains have previously been described to be
either haemagglutinating or non-haemagglutinating [23]. We
tested all 6 strains of RHDV on human A, B and O blood
(Table 1). All RHDV strains were able to agglutinate B blood
consistent with B type 2 recognition. The G2 and G3 strains also
showed strong binding to H type 2 on O RBC. G1 and G5 showed
weak binding to O RBC, while G4 and G6 did not agglutinate O
blood. G1 was able to agglutinate A blood to the same extent as B,
whilst all other strains showed weak agglutination of A, indicating
B type 2 as a ligand for G1–G6, H type 2 as a ligand for G2 and
G3 and A as a ligand for G1.
ABH antigens expression on rabbit tissues
To study HBGAs expression and distribution in the rabbit
duodenum and trachea, the proposed sites of viral entry, as well as
in the liver, a major site of replication, monoclonal antibodies
against A and B as well as Ulex europaeus lectin (UEA-I) were used
to detect A, B and H type 2 (Le
y) on wild rabbit tissue sections,
respectively (Fig 4). HBGA expression was always restricted to
epithelial cells. The nine French wild rabbits tested were found to
be either A and B positive (A+B+) at the duodenum surface or A
and B negative (A2B2). Staining with UEA-I was much stronger
and homogenous on sections from A2B2 rabbits (data not
shown), suggesting partial masking of H type 2 by the A and B
epitopes. In addition, expression of the B antigen appeared to
differ from those of the A and H antigens. A, B and H were
expressed on the crypts of Lieberku ¨hn (surface layer of the mucosa)
and not on the Bru ¨nners’ glands (deep layer). Yet, staining by the
anti-B appeared more patchy and irregular than staining by the
anti-A and it was always weaker. In addition, in A+B+ animals, A
antigen, but not B antigen was detected on the surface of the
trachea and on the biliary ducts of portal spaces in the liver.
Neither A, B or H antigen could be detected on the liver
parenchyma.
Analysis of rabbit HBGA diversity
In order to get insights into the diversity of HBGA expression in
rabbits, a more quantitative assay was needed. Therefore, fresh
rabbit duodenums were collected from 84 rabbits of both wild and
laboratory origin for more detailed studies of ABH expression and
RHDV binding. A semi-quantitative ELISA system for rabbit
duodenum scrapings determined that all animals do express either
H type 2, A or B. No animal was found to be of a clear non-
secretor phenotype as described for humans, and all rabbits
expressed detectable levels of either H type 2 or A and/or B, albeit
with great individual variations and where A expression generally
was stronger than B. Ranking animals by increasing H type 2
detection clearly showed an inverse relationship with A expression
and to a lesser degree with B expression, indicating that A and B
epitopes mask the H motif (Fig 5 and Table S2). Based on the
detection of the A or B antigens, animals were phenotyped A+B+,
A2B2 or A+B2 with the respective frequencies 0.52, 0.38 and
0.1 respectively.
The carbohydrates of the rabbit duodenum were further
characterized through mass spectrometry (MS). Both N-linked
and O-linked glycans were analyzed and blood group antigens
have been mainly found on O-glycans, while N-glycans are largely
terminated with galactose or sialic acid with virtually no fucose on
their antennae (Fig S1). Many of the O-glycan’s peaks identified
through MALDI-TOF analysis (Table S4) have been shown to be
a mixture of different structures after MS/MS analysis (Fig S2). In
O-glycans, we observed a predominance of core 2 structures,
followed by core 3 (Fig 1C). The smallest fucosylated glycan was
observed at m/z 708, corresponding to a core 1 fucosylated
trisaccharide bearing a blood group H epitope, while the largest
fucosylated glycan had a composition of 8 residues arranged on a
biantennary core 2 structure (m/z 1822) with one antenna
carrying an A blood group epitope (Fig 6). Most of the samples
analyzed showed high abundance peaks at m/z 708, and/or at
RHDV Strain and Host-Dependent Glycan Interactions
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corresponding to different structures in different samples: after
MS/MS sequencing, a mixture of core 1, 2 and 3 structures
bearing blood group H, A and Lewis epitopes have been observed
(Fig 6 and Fig S2). A peak at m/z 1199, with composition
HexNAc3, Fuc, Hex, has also been observed in most of the
samples analyzed, showing after MS/MS sequencing a core 3
structure carrying an H or Lewis X epitope in some of the rabbits,
while in other rabbits it was recognized as a core 2, 3 and 4 with
terminal A blood group on one antenna (Fig 6 and Fig S2). In 3 of
the 10 samples analyzed, a peak at m/z 1373 was found, with
composition HexNAc3, Fuc2, Hex, and after further analysis it
was found to be a core 3 structure carrying a blood group A
epitope (Fig S3). Detailed compositions of O-glycans of the 10
samples analyzed are reported in Table S3. In summary, we
observed a high variety of O-glycan structures carrying blood
group antigens H, A and B (Table S3). Blood group antigen B has
been detected in samples 1, 4, 5, 6, 8, and 9 for a total of six B
positive rabbits out of ten analyzed, in accordance with data from
antibody binding analysis, while blood group antigen H has been
detected in nine out of ten samples analyzed and only sample 9 did
not show any glycan bearing H blood group epitopes. Mass
spectrometry analysis could not distinguish between type 1 or type
2 based antigens but we observed poor reactivity on rabbit
duodenal extracts of an anti-H type 1 specific antibody compared
to the UEA-I reactivity, recognizing H type 2. On human saliva
from O secretors, both reagents reacted equally well, suggesting
that in rabbit duodenum, there is little, if any, type 1 based histo-
blood group antigens (data not shown). In all of the 10 rabbits,
both wild and domestic rabbits, detection of the B type 3 structure
by mass spectrometry matched the B phenotype obtained with an
anti-B antibody showing broad specificity toward all types of B
antigens (Table 2). In contrast, detection of A histo-blood group
structures by mass spectrometry and using a broadly reactive anti-
A did not match. Thus, although three animals were unequivo-
cally phenotyped as A-, the A type 3 structure was found in all 10
rabbit duodenum samples analyzed by mass spectrometry. A type
2 was only found in the rabbits that through antibody detection
were determined to be A+, though two of the A+ phenotyped
rabbits did not express A type 2. In order to determine if the
discrepancy between the MS and the phenotyping results for the A
type was not due to the specific anti-A that was used in the first
place, the A- rabbits were then phenotyped again with several
other broad binding, anti-A specific antibodies with confirmed
recognition of the PAA-conjugated A trisaccharide. Yet, despite
attempts to amplify the signal, the A- phenotyped rabbits
remained A-, indicating that in some animals, although present,
A type 3 epitopes are not detected on duodenum extracts by
ELISA or immunohistochemistry, and the phenotypes of the 10
rabbit duodenum samples as determined by ELISA are noted in
Table 2. Despite this discrepancy, it remains that both the A+
versus A2 and B+ versus B2 phenotypic dichotomies are as clear-
cut as the A or B versus O distinction between humans.
Analysis of RHDV strains binding to rabbit tissues
To determine the sites of RHDV attachment to the duodenum,
A+B+ rabbit duodenum sections were used and all six strains were
found to bind to the duodenum surface but not the Bru ¨nner’s
gland, in accordance to A, B and H type 2 expression as discussed
above. Binding was also detected on the surface epithelium of the
trachea that expresses detectable amounts of H type 2 epitopes
despite expression of A antigen, but not on the biliary ducts in the
liver where B and H type 2 epitopes are not detectable in A+B+
animals (Fig 4).
The six strains of RHDV were then analyzed for binding to
duodenum extracts using the same semi-quantitative system as for
ABH phenotyping. Virus binding and ABH phenotypes were
normalized, to account for variation of duodenum scraping,
against Concanavalin A binding, a lectin which binds mannose of N-
glycans. To analyze relationships between A, B or H expression
and virus binding, animals were separated into three equal groups
of weak, medium and strong binders and correlated to A, B and H
presence or absence. G2 binding was significantly correlated to H
type 2 expression. G3 binding did not correlate with the presence
of either A, B or H antigen. G4, G5, G6 and G1 binding
significantly correlated to A and B expression and inversely
correlated to H type 2 expression, with the exception of G6
binding which did not correlate to B expression (Table 3, Table
S5). It should be noted that most animals that express A also
express B (A+B+ or A2B2 phenotypes). Therefore in this
association study, A and B antigens are linked. Nevertheless, a
small subgroup of rabbits expresses A independently of B (A+B2
phenotype) (Table S2). This subgroup was significantly associated
with low G2 binding (p=0.006) and inversely with strong G4, G5,
G6 and G1 binding (p,0.05). In order to visualize differences in
binding of these strains to individual animals, rabbits were ranked
according to G4 binding in increasing order (Fig 7). Keeping the
same order of relative binding for the five other strains clearly
showed important individual differences with animals strongly
recognized by some strains but poorly by others. Each strain
showing a unique binding pattern, despite similar binding
characteristics of G4, G5 and G6 as described above.
RHDV binding after enzymatic removal of ABH antigens
To confirm that binding of each strain to rabbit duodenum
extracts required the presence of A, B or H epitopes and to get a
more complete picture of the strains specificities, A, B or H
antigens of duodenal extracts were removed with specific
glycosidases prior to virus binding assay. Extracts from three
rabbits of three different phenotypes (A2B2,A +B+ and A+B2)
were treated with either a galactosidase or an N-acetyl
galactosaminidase, removing the galactose (Gal) of B or the N-
Figure 2. Evolutionary tree of RHDV strains and non-pathogenic rabbit calicivirus strains (RCV, RCV-A1 and MRCV) according to
nucleotide sequences of the gene encoding the capsid protein VP60. The 6 RHDV strains used in this study are marked with a dot (GenBank
accession numbers: G1 JF438967, G2 FR823355, G3 FR823354, G4 AJ535094, G5 AM085133, and G6 AJ969628). The genetic group of each strain (G1
to G6 according to Le Gall-Recule ´ et al.[17] and Group 1 to 4 according to Kerr et al. [20]) is annotated. For the G1 strain, the genetic group is noted as
defined in Muller et al. [19] (IB2a). Capsid sequences where recombination was previously detected were excluded from the analyses [76,77]. The
newly obtained sequences were checked for recombination using RDP3 [78]. Evolutionary distances were computed using the p-distance method.
Alignment gaps and missing data were eliminated only in pairwise sequence comparisons (Pairwise deletion option). The European brown hare
syndrome virus strain (GenBank accession number X98002) was used as an outgroup to root the tree. The tree was constructed using the neighbor-
joining method [79] with the pairwise deletion option. Reliability of the tree was assessed by bootstrap with 1000 replicates and is indicated in the
nodes for relevant clusters. Several genetic distance methods were used and similar results were obtained, but only p-distance is shown. The
phylogenetic analyses were conducted in MEGA 4 [80]. Similar trees were obtained using the Maximum Likelihood (ML) method as implemented in
Garli v1.0 [81].
doi:10.1371/journal.ppat.1002188.g002
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role of A and B binding in the duodenum, followed by an a1-2
fucosidase to remove the fucose of H type 2 (Fig 8). Efficacy of
each enzyme was determined by testing the binding of either an
anti-A, an anti-B or UEA-I before and after treatment. The results
shown in Fig 8D indicate that the fucosidase removed H type 2
almost completely, whereas treatments with either the N-acetyl
galactosaminidase or the galactosidase only resulted in a partial
removal of the A and B antigens, respectively. Removing the
fucose of H type 2 confirmed that binding of all RHDV strains to
Figure 3. RHDV strains binding to synthetic oligosaccharides. RHDV liver extract binding used in a range of dilutions for detection of binding
to human serum albumin (HSA) and polyacrylamide (PAA) conjugated oligosaccharides. Vertical grey line symbolizes the same amount of viral RNA,
whereas the dotted line symbolizes the same amount of viral RNA as the solid lines, though detected with a different antibody system since the G6
strain was less well recognized than the other strains by the Lp4 polyclonal antibody.
doi:10.1371/journal.ppat.1002188.g003
Table 1. RHDV agglutination titres of human red blood cells.
G2 G3 G4 G5 G6 G1
Type O 2048 512 0 8 0 16
Type A 2 32 2 16 16 256
Type B 4096 1024 256 512 128 256
doi:10.1371/journal.ppat.1002188.t001
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cleavage of the GalNAc sugar of A followed by removal of the
fucose of H type 2 confirmed the significance of RHDV binding
and the importance of A antigen expression (Fig 8B). Indeed, for
G2 which was the only strain unable to recognize the A synthetic
oligosaccharide and to show no relationship between RHDV
binding and A expression, cleavage of the GalNAc residue of A
allowed binding since it resulted in appearance of the underlying
H type 2, which became accessible for binding. Inversely, the G1
strain preferred binding to A over H type 2, as seen in the
decreased binding after removal of the A epitope, consistent with
the results of agglutination. The other strains were not affected by
the removal of A but showed a clear decrease of binding following
removal of both A and H, indicating similar binding to A as to H
Figure 4. Immunohistochemistry of A, B and H expression and RHDV binding to duodenum and trachea. Staining of the duodenum,
trachea and liver of A+B+ rabbits by an anti-A, an anti-B and the H type 2 specific UEA-I lectin. Binding of RHDV (shown a G3 strain) was performed by
incubating liver extracts on tissue sections followed by detection using an anti-RHDV monoclonal antibody as described in the ‘‘materials and
methods’’ section. Negative controls correspond to section where the liver extracts were omitted. The simple bar corresponds to 100 mm and the
double bar to 200 mm. A 4x higher magnification is inserted into the RHDV/duodenum picture, showing the labeling of the crypt epithelial cells. The
white star is the Lieberku ¨hn crypts (surface layer of the duodenal mucosa). The black star is the Bru ¨nners’ glands (deep layer of the duodenal mucosa).
The arrow indicates the epithelial layer of the trachea. The triangle indicates the liver parenchyma.
doi:10.1371/journal.ppat.1002188.g004
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GalNAc followed by removal of H type 2 of an A+B+ rabbit
indicated a major importance of B in the presence of A, as removal
of the Gal of B followed by removal of the fucose of the underlying
H type 2 abolished binding for G1, G2, G3 and G5 (Fig 8C). G4
and G6 binding also preferably bound B over A as removal of B
decreased binding, whereas removal of A did not affect binding, or
even slightly increased RHDV binding. However, neither G4 nor
G6 binding was further decreased after removal of H as A was still
expressed in the duodenal scrapings, allowing for binding of G4
and G6. Thus, the results of RHDV strain binding so far indicates
binding of G2 to H type 2 and B, while the other strains are able to
bind A, B and H type 2 with variable strength.
Rabbit challenge with infectious RHDV
Human norovirus binding to HBGA’s has been determined to
correlate with symptomatic infection in human volunteer studies
and in outbreak studies. To determine the importance of
carbohydrate binding regarding RHDV infection, domestic
rabbits were challenged with the G4 strain (GenBank accession
number AJ535094). This genetic group was chosen because it
proved to be strongly dependent on binding to A and B antigens
and because a breed of rabbits with a previously determined high
A2B2 frequency (63%) was available at the animal facility. Pre-
challenge serum was collected from 6 of the animals, and no
RHDV antibodies were detected. In addition, the rabbits from this
animal facility proved negative during routine screening for the
non-pathogenic calicivirus strain. Furthermore, any protection
from cross-reacting antibodies can be excluded as non-pathogenic
calicivirus strains circulating in France have been shown to
provide no protection against RHD [12]. The 12 week old rabbits
were then infected orally with 10
5,1 0
7 or 10
9 genome copies of a
G4 liver extract. At necropsy of dead rabbits, typical RHD lesions
were observed. Surviving animals were sacrificed 11 days after
infection, however one rabbit within the highest infectious dose
group was sacrificed 7 days post infection due to ethical
considerations as it seemed severely ill. Post-mortem examination
confirmed the presence of RHD lesions. Duodenum and liver
samples were collected from all of the rabbits post-mortem. 7/10,
6/11 and 3/10 rabbits died from RHDV with an average survival
time of 3.5 days, 3.5 days and 5 days in the groups infected with
10
9,1 0
7 and 10
5 genome equivalents, respectively (Fig S5). Post-
mortem ABH duodenum phenotyping of the rabbits determined
3, 3 and 4 A+B+ rabbits in the 10
5,1 0
7 and 10
9 infectious dose
groups, respectively, the remaining animals being A2B2
(Table 4). Analysis of the ABH duodenum phenotype and G4
binding to the duodenum of all infected animals resulted in a B
expression well correlated with virus binding of the rabbit
duodenum of the infected animals (r
2=0.78) (Fig 9A). Neverthe-
less, it should be noted that all animals were recognized by the G4
strain, albeit with great individual variation. Real time RT-PCR of
RNA isolated from the duodenum and liver of the rabbits revealed
viral replication in the liver of all animals (Fig 9B). The RNA levels
in both liver and duodenum of rabbits succumbed to infection
were significantly higher than viral RNA levels of rabbits sacrificed
at 11 days post infection (Mann-Whitney, p,0.0001). It should be
noted that this difference might be partly due to the difference in
sampling time between dead and surviving rabbits (3–5 days vs 7–
11 days). Within the rabbits infected with the lowest dose of 10
5
genome copies all A+B+ rabbits (n=3) died, while all A2B2
rabbits (n=7) survived the infection (p=0.008, Fischer’s exact test)
(Fig 9C, D, Table 4). This was however not the case for the two
higher-dose challenges (Fig S4, Table 4), indicating that A and B
binding facilitates infection, though the lack of A and B antigens
can be overcome by a high viral dose.
Analysis of ABH phenotypes in wild rabbit populations
affected by RHDV
In order to study possible selection of ABH phenotypes after
RHDV outbreaks, rabbit duodenums were collected from two
populations located 15 km apart near Perpignan, southern France,
where detailed information was available regarding RHDV.
Rabbits were sampled by hunters from the two different
populations, Claira and Canohe `s. The Claira population had
never been affected by an RHDV outbreak. The Canohe `s
population was heavily reduced during September 2006 by
RHDV, where G5 was the primary RHDV- circulating in the
area, though Iberian G1 strains were also detected during this
period, and the population size strongly decreased (Ste ´phane
Marchandeau, personal communication). Twenty two rabbit
duodenums were collected in 2009 from the Claira population
and only 5 from Canohe `s due to the low density of rabbits in the
population. All of the 5 rabbits sampled from the Canohe `s
population were B-, and all of them, either of the A+B2 and
A2B2 subtypes, were significantly lower binders of G5, and
similar binding results were seen with G1 (Table 5). In contrast,
the Claira population where RHDV had never been detected had
a high frequency of A+B+ (82%) and therefore only few B2
animals (18%). Since the G5 strain binds preferentially to the B
antigen, these results suggest that the B2 phenotype could have
been selected at Canohe `s following the devastating 2006 outbreak.
In Australia, rabbits have been repeatedly infected with the G2
Czech strain of RHDV to control the rabbit population. Infecting
a rabbit population with the same strain gives an interesting
perspective to study selection from a single RHDV strain. Rabbits
were sampled at three different locations, Hattah, Bendigo and
Bacchus Marsh. Experimental challenges with RHDV have shown
the Hattah and Bacchus Marsh populations to have developed
partial resistance to infection (Brian Cooke, personal communica-
tion) and the non-pathogenic, partially protecting virus RCV-A1
has been detected in the Bendigo and Bacchus Marsh populations,
but not in the Hattah population [15]. Rabbit duodenum extracts
were analyzed for ABH phenotype and G2 strain binding. Similar
to the above described French G2 strain, the Czech G2 strain
bound Australian A+B2 rabbits poorly (Table 6). The G2 Czech
strain also showed binding to synthetic B and H, but not A, similar
to the French G2 strain used above. In addition, both strains
showed poor binding to the A+B2 individuals regardless of the
animals’ origin (data not shown). Hattah was the population of the
significantly highest frequency of A+B2 rabbits and inversely with
the lowest frequency of A2B2 animals, which are most frequently
strongly recognized by the G2 strains, suggesting selection for a
subgroup of rabbits with potential of protection against infection
with a G2 strain.
Discussion
A recent study of the phylodynamics of RHDV indicated that
France has been the most important source population for RHDV
[20]. Although this may be due to sampling bias, a chronological
Figure 5. Expression of H type 2, A and B in rabbit duodenum. Relative expression of H type 2, A and B where the individual rabbits are
sorted according to H type 2, A and B. A- rabbits are shown with stars in graph of H type 2 expression.
doi:10.1371/journal.ppat.1002188.g005
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established in France for the G2 to G5 strains [17]. The G1
strain used in the present study is a recent strain of Iberian origin
and G6 strains showed no apparent chronological link with other
strains. In France, G1 and G2, which includes the strain isolated
in the first reported outbreak in China in 1984, have not been
isolated since 1990, though G1 currently circulates almost
exclusively on the Iberian Peninsula. In addition, since 2000 a
few Iberian G1 strains have been identified in the South of
France, along the Spanish border [19]. This may be the result of
virus spread across the Pyrenean Mountains via insects or the
wind [22]. The Iberian strains, suspected to originate from a
single introduction of G1, have evolved separately from the other
RHDV strains and cluster into 6 Iberian clades (IB1 to IB6) [22].
G3 has been isolated in France between 1990–1997 and G4 has
been isolated from 1993–1999. G5, originally first detected in
1994 and G6 first detected in 1999 are both currently circulating
in France. G6 corresponds to the first antigenic variant identified,
RHDVa [18]. Although the neighbor-joining tree constructed
using nucleotide sequences allowed the allocation of the strains
tested into each of the six previously identified genetic groups, it is
comparable to the topology presented by Kerr et al. [20]. That
the G3, G4 and G5 genetic groups did not appear as clearly
independent as previously reported [17] might be due to the use
of complete nucleotide sequences of the capsid in the more recent
studies [20] rather than just partial sequences used in the earlier
study [17]. Alternatively, this can also be a result of the inclusion
of strains that cover most of the worldwide genetic diversity.
Nevertheless, the topology of the tree is highly supported by the
bootstrap values which are all above 90% for the major nodes.
Neighbour joining trees were constructed using amino acids
sequences of the entire capsid or of the P2 subdomain with the
aim to infer a correlation between the HBGA binding profiles
and the evolution of RHDV. No such correlation was observed
(data not shown). Regardless, the trees constructed using either
nucleotide or amino acid sequences showed that that the six
selected virus strains G1 to G6 represent a good cross section of
the antigenic diversity amongst the known pathogenic forms of
RHDV.
The gastrointestinal tract is protected by a thick layer of O-
glycans constituting the glycocalix of epithelial cells or presented as
soluble mucins. It is therefore not uncommon for pathogens of the
gastrointestinal tract to interact with such carbohydrates to be able
to access the underlying epithelial cell membrane. A major route
of transmission of RHDV is the fecal-oral route and so far viral
RNA of the closely related non-pathogenic viruses have been
exclusively recovered from the small intestine [11,12,13], suggest-
ing that these viruses are primarily enteric viruses but that the
pathogenic strains do not remain confined in the gut [24,25].
Since an RHDV strain was previously shown to bind to a
carbohydrate structure expressed in the gastrointestinal and upper
respiratory tracts of rabbits [21], in the present study we first
aimed at determining if this characteristic was shared by other
pathogenic strains belonging to different clusters of the RHDV
phylogeny and this was analyzed by several methods. Analysis of
the binding to a set of HBGA related synthetic neoglycoconjugates
revealed distinct binding patterns between strains, although strong
binding to the B type 2 motif was common to all strains. The
strong H type 2 binding previously observed for a G2 strain was
confirmed but the magnitude of H type 2 binding was quite
variable among strains. All strains except G2 and G3 were able to
bind the A epitope and binding to Le
y was observed only for G1
and G6. The uniquely strong binding of G1, a strain restricted to
the Iberian Peninsula, to Le
y suggests an important role of the host
genetic background. G1 is the only genetic group present in that
region, a fact that might be correlated with the Pyrenees acting as
a barrier to the dispersal of both the virus and rabbits, but also by
the fact that the European rabbit originated in that area and that
populations of other parts of the world consist of only a subset of
that original gene pool [26,27,28,29,30]. The higher genetic
diversity of the Iberian rabbits may be reflected in the need of the
virus to explore other carbohydrates for binding.
Table 2. Detection of A and B with mass spectrometry and antibodies.
AB
Rabbits Mass spectrometry Antibody Mass spectrometry Antibody Phenotype
1 A type 3 + B type 3 + A+B+H2
2 A type 3 22 2A2B2H+
3 A type 3 22 2A2B2H+
4 A type 3; A type 1/2; A Lewis b/y + B type 3 + A+B+H2
5 A type 3; A type 1/2; A Lewis b/y + B type 3 + A+B+H2
6 A type 3; A type 1/2; A Lewis b/y + B type 3 + A+B+H+
7 A type 3; A type 1/2 + 22 A+B2H2
8 A type 3 + B type 3 + A+B+H+
9 A type 3; A type 1/2 + B type 3 + A+B+H2
10 A type 3 22 2A2B2H+
doi:10.1371/journal.ppat.1002188.t002
Figure 6. MALDI-TOF MS of O-glycans released from Rabbit Duodenum. Glycans were permethylated prior to MALDI-TOF analysis.
Structures were assigned taking into account the molecular weight value and the fragment ions obtained upon MS/MS analysis. Non annotated
structures correspond to non fucosylated O-glycans and permethylation adducts. A: Profile of fucosylated permethylated O-glycans released from
rabbit duodenum (Sample 2). B: Profile of fucosylated permethylated O-glycans released from rabbit duodenum (Sample 4). C: Profile of fucosylated
permethylated O-glycans released from rabbit duodenum (Sample 6).
doi:10.1371/journal.ppat.1002188.g006
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specificity for isolated carbohydrate motifs but the presentation
and density of the sugar on the scaffold may not mimic expression
in the tissue or on cell surfaces. In order to confirm that all RHDV
strains bind to HBGAs, albeit with some differences in specificity,
binding to human red blood cells (RBC) that express type 2 based
HBGAs (H type 2 on O RBC, A type 2 on A RBC and B type 2 on
B RBC) was examined through agglutination. All strains tested
agglutinated human erythrocytes. They showed distinct blood
group specificities, although here also a common feature was B
blood group recognition. The ability of RHDV to agglutinate
human RBCs has been observed soon after the virus discovery [2],
although the existence of non-agglutinating strains was later
reported [23,31]. As the six strains that we tested spanned the
RHDV phylogenetic diversity, our results suggest that all RHDV
strains could be agglutinating. There was no indication of the
RBCs blood groups used in the reports of non-agglutinating strains
[23]. The use of O or A RBCs could thus well explain why some
strains appeared non-agglutinating. Regardless, our results show
that the ability of RHDV to recognize HBGAs has been
maintained throughout RHDV evolution but with somewhat
distinct strains specificities. We therefore investigated whether
rabbits showed HBGA diversity.
HBGA expression in rabbits has previously been reported
through analysis of glycolipids of the small intestine or by
immunohistochemistry in the small and large intestines, respec-
tively [21,32,33,34]. However, the diversity of expression in the
small intestine of individual animals has not been studied
previously. We observed here that rabbits are able to express
either A, B or H (Le
y), mainly based on type 2 and type 3
precursors. With immunohistochemistry, nine wild rabbits tested
were found to be either A+B+ or A2B2. A and B were expressed
on the duodenum surface mucosa, whereas the underlying
Bru ¨nners’ glands were negative. Expression of A appeared
stronger than B expression, and in tissues as trachea and bilary
ducts where A and H type 2 expression was weak, B was negative,
which was further confirmed with the semi-quantitative phenotype
assay. In both assays, the concentration of anti-B necessary to
detect the presence of B epitopes was at least 10 times higher than
that required to detect B antigen either on human epithelial tissues
or saliva. In contrast optimal dilutions of anti-A or UEA-I were
similar to detect A or H epitopes in both species. This clearly
indicated that in rabbits, B antigen was present in smaller amounts
than A and H, or that it was less accessible. Mass spectrometry
analysis of the duodenum determined that HBGA motifs were
mainly present on O-linked rather than on N-linked glycans and
revealed extensive individual variation. This great individual
variation was also found through a semi-quantitative analysis of A,
B or H expression with specific reagents. Strikingly however, no
rabbits, out of over 200 screened individual duodenums, were
found to completely lack expression of A, B or H, indicating that a
clear-cut non-secretor phenotype does not exist in rabbits, unlike
in humans. These data are in line with the findings of Guillon et al.
[35] who observed that despite a large polymorphism of the Fut2
and Sec1 coding sequences of wild rabbits, involved in synthesis of
H type 2 and H type 3, all of the detected Fut2 enzyme variants
were functional, indicating that the genetic diversity of H
expression in rabbits is controlled by the level of expression of
the a1,2fucosyltransferases or by other as yet unknown mecha-
nisms, but not due to null alleles of an a1,2fucosyltransferase gene
like in humans. Antibody binding data and mass spectrometry
were in accordance for detection of B antigen amongst the 10
rabbits analyzed with mass spectrometry, revealing B+ and B-
rabbits. As for detection of A antigen, there was divergence
between the mass spectrometry data and the antibody binding.
Three rabbits with detectable A epitopes in mass spectrometry
appeared A negative using antibodies, despite the use of 4 different
well-characterized antibodies able to bind all types of A. For
reasons still unclear, all A epitopes are not accessible to antibody
binding. A possible explanation is that the A antigen of these three
rabbits is exclusively of type 3, i.e. very short O-glycans where
larger surrounding glycans may sterically hinder binding of the
antibodies. A second complication may be that glycans may be
present not only on proteins but also on glycolipids. Earlier work
on glycolipids from rabbit small intestine showed expression of A
type 2 and B type 2 in the small intestine of rabbits [33,34]. A
differential expression of A on O-glycans and glycolipids along
with difficult detection of the short A type 3 may account for the
difference between mass spectrometry analysis and antibody assay.
A complete understanding of the ABH polymorphism in rabbits
will require a full genetic description of the system, which appears
quite different from that in humans. Thus the frequencies of the
different A and B phenotypes (A+B+,A +B2 and A2B2) in the
various populations that we studied cannot be explained by the
polymorphism of a single ABO gene as in humans and our
preliminary genetic analysis indicates that there are at least 6 Abo
genes in rabbits located in tandem in the genome. A similar
situation has already been described in rats which have been
reported to have a variable number of Abo genes (up to 5), with
some genes encoding A enzymes and others encoding B enzymes
[36,37]. Therefore, despite a generally conserved expression of
ABH antigens across mammalian species, the genetic mechanisms
leading to diversity of expression and intraspecies polymorphism
are quite variable. Here the major observation regarding rabbits is
that they present extensive individual variability of A, B and H
expression in the duodenum which is a primary site of attachment
for RHDV leading us to analyze the relationships between ABH
expression and the binding properties of different strains.
As rabbit duodenums express complex patterns of HBGAs,
statistical calculations were used to reveal relationships between
individual RHDV strains binding and HBGA expression. Strong
relationships were established with A+B+,A +B2 and A2B2 in a
strain-specific manner, though the relative importance of each
epitope was not completely clear. Enzymatic removal of each A, B
or H epitope allowed a better assessment of the role of each of
Table 3. Correlation between weak, medium and strong
RHDV binding and A, B and H type 2 expression or no
expression.
RHDV strains A B H type 2
G2 NS NS *
G3 NS NS NS
G4 *** ** *
{
G5 *** ** *
{
G6 *** NS *
{
G1 ** ** *
{
For each strain, animals were split into 3 equal groups according to the
intensity of binding (weak, medium or strong) and association with A, B and H
type 2 expression or lack of expression was tested by chi-square analysis. NS =
not significant.
*p,0.05.
**p,0.005.
***p,0.0005.
{correlation with low binding (inverse correlation).
doi:10.1371/journal.ppat.1002188.t003
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nor H specific but more or less dependent on the level of
expression of each of these antigens. Nevertheless and most
importantly, for each RHDV strain, binding to individual
duodenum extracts ranged from very weak to very strong, with
the various strains clearly showing differential recognition of
individual animals. Considering the results of the binding assay to
synthetic sugars, of human RBCs agglutination, of the association
with rabbits ABH phenotypes and of the enzymatic removal of
ligands, G2 binds to B antigen as well as to H type 2 but is not able
to recognize A. As a result, due to the masking of H type 2 by A,
G2 only poorly binds to A+B2 animals. Interestingly, strains
which later displaced G2 in France, G3–G6, as well as G1 are all
able to bind A. G3 was able to bind A, B and H type 2, which
explains why no significant association was found between
duodenum binding and rabbit ABH phenotypes. G4, G5, G6
and G1 preferentially recognized A+B+ or A+B2 animals over
A2B2 animals. For these strains, binding to duodenum samples
was more strongly associated with the presence of A antigen than
of B antigen and inversely associated with the presence of H
Figure 7. Binding of 6 RHDV strains to rabbit duodenum. Relative binding of G1–G6 to 84 individual wild and non-wild rabbit duodenums.
Rabbits are ordered according to G4 binding in all graphs. The rabbits below the detection threshold of G4 and therefore in no particular order are
displayed with gray bars.
doi:10.1371/journal.ppat.1002188.g007
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removal indicated a greater importance of B over A despite an
apparent higher expression of A antigen compared to B antigen in
the duodenum. This apparent discrepancy can be explained by
their stronger binding to B antigen than to A antigen along with
the fact that B antigen is always present when A antigen is also
expressed whereas A antigen can be expressed in absence of B in
A+B2 animals. The ability to bind the A+B2 animals therefore
explains the stronger association with A than with B expression.
Nevertheless, despite similar binding patterns between G4, G5, G6
and G1, these strains showed slight differences resulting in
different recognition patterns for individual rabbits. A schematic
diagram summarizing these observations is presented in Fig 10.
Although HBGA binding has been determined as crucial for
symptomatic infection by norovirus in humans (see below), the role
of HBGA binding has not been directly established for RHDV
infection of rabbits. For this purpose G4, a strain with a marked B-
specific and to a lesser extent A-specific binding, was used in a
challenge experiment in combination with a rabbit breed of
domestic rabbits with high A2B2 frequency. When rabbits were
challenged with 10
5 genome copies there was a clear relationship
between survival and the A2B2 phenotype (or low virus binding)
but the relationship vanished at higher virus challenge doses. It
should be noted that duodenum extracts of all animals were
recognized by the G4 strain, although binding to some individuals
was weak. Thus, infection with a high viral dose can compensate
for weak viral binding to HBGAs. The increased survival rate at
low infectious doses was not achieved by avoiding infection.
Regardless of their survival, all rabbits in the experimental
challenge study had detectable levels of RHDV-RNA in the
duodenum and liver, indicating that all rabbits became infected. In
addition, the groups infected with high doses of virus (10
9 and 10
7)
still showed untypically high survival rates (30% and 54%,
respectively), and lower virus loads in the tissues of the survivors.
These findings suggest additional mechanisms of controlling the
RHDV infection, leading to a less severe course of the disease and
overall lower virus titers. In addition, G4, a strain no longer
detected in France, may have been less virulent than other
circulating strains. Noteworthy, hepatocytes are prone to potent
viral propagation despite being completely devoid of HBGA [38].
Thus, our results suggest that HBGAs function as an attachment
factor rather than the main cellular receptor.
Previous studies show that the amount of virus in fly spots from
flies feeding on RHDV infected livers were sufficient to infect
rabbits [39]. Similarly, it was shown that as few as 1 to 10 viral
particles may be sufficient for infection with human noroviruses
[40]. Thus, it is conceivable that 10
7 or 10
9 genome copies
correspond to very high amounts of viral infectious particles, much
higher than the doses involved in natural transmission during
RHDV outbreaks. It is therefore likely that mechanisms allowing
protection at low infectious doses will have noticeable effects on
rabbit survival rates during natural outbreaks.
In order to investigate if selection pressure from RHDV leads to
increased frequencies of low binding HBGA phenotypes in natural
populations, wild rabbits from several locations in France and
Australia were investigated. As rabbit populations are closely
Figure 8. Enzymatic removal of A, B and H from three different rabbit duodenums. The H epitope was cleaved from an A2B2 rabbit
duodenum and G1–G6 binding was tested against H removal and a mock treated control (A). A and H were cleaved from an A+B2 rabbit duodenum
and RHDV binding was tested against A removal, A followed by H removal and a mock treated control (B). A, B and H were removed from an A+B+
rabbit duodenum where A removal, A and H removal, B removal, B and H removal and a mock treated control were tested for G1–G6 binding (C).
Control of the enzymatic removal of A, B and H are shown (D).
doi:10.1371/journal.ppat.1002188.g008
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known RHDV-infection history that may have been under
selection pressure for weak binding HBGA phenotypes. We had
access to rabbits from two different French wild rabbit populations
located 15 km apart. The first site, Claira, carries a high density
population of rabbits in an area otherwise heavily hit by RHDV
outbreaks, and has no evidence of previous RHDV infection. The
second site, Canohe `s, has a population recovering from a major
RHD outbreak due to a G5 (or possibly Iberian G1) strain in
September 2006 that left few survivors, and small additional
mortalities were again recorded in 2007 and 2008. Despite the
limited sample size from the recovering population, we observed a
highly significant weaker G5 and G1 binding associated with B-
phenotypes among the descendants of RHDV survivor rabbits
when compared to the neighboring control population, suggesting
that the virus contributed to select animals with a weak binding
HBGA phenotype.
In Australia, RHDV has been purposely introduced in 1996 to
limit the damage caused by rabbits. RHDV quickly proved to be
efficient at drastically limiting the population size [41], however in
recent years rabbit survival has again increased due to several
factors, such as development of immunity in the populations
[42,43], facilitated by partially cross-protecting antibodies from
infection by non-pathogenic caliciviruses [15]. In addition, the
appearance of genetic resistance to RHDV has recently been
observed at some locations where the virus had previously proven
very efficient at eliminating rabbits (Brian Cooke, personal
communication). Rabbits were sampled from three different
populations in Victoria, Hattah Kulkyne National Park, a site
with indication of genetic resistance to RHDV and no protection
from the non-pathogenic RCV-A1, Bacchus Marsh, a population
with resistance to RHDV and protection from circulating RCV-
A1 and Bendigo with little resistance to RHDV and with
circulation of RCV-A1(Tanja Strive, unpublished results) [14].
We found the A+B2 frequency to be significantly increased in the
Table 4. A+B+ and A2B2 phenotypes and survival and
death of rabbits from G4 challenge experiment.
A+B+ A2B2
Survived Dead Survived Dead
10
5 dose 0 3 7 0
10
7 dose 2 1 3 5
10
9 dose 1 3 2 4
doi:10.1371/journal.ppat.1002188.t004
Figure 9. RHDV challenge of A+B+ and A2B2 rabbits. 31 rabbits were infected with an A and B binding G4 strain at 10
5,1 0
7 or 10
9 virus
copies. Rabbits either succumbed to infection or were sacrificed after 11 days. Duodenum and liver samples were collected at time of death.
Duodenum was phenotyped for A, B and H expression and G4 binding. Duodenum and liver were also assayed for virus RNA via real time RT-PCR. (A)
G4 binding plotted against B expression levels. (B) Viral load of liver and duodenum of all dead and surviving rabbits. Duodenum RNA is plotted as
arbitrary units since the RNA was normalized against b actin to account for tissue preparation variations. Liver RNA is plotted as copy numbers since
the tissue state due to infection did not allow for reliable quantification of rabbit RNA. (C–D) Virus RNA levels of liver or duodenum for 10
5 infectious
dose, where A+B+ (circle), A2B2 (triangle), dead rabbits (black symbol) and surviving rabbits (white symbol).
doi:10.1371/journal.ppat.1002188.g009
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binding of both the French G2 strain as well as the G2 Czech, the
only strain currently circulating in Australia. The presence of a
partially protective benign calicivirus in the two other populations
likely resulted in increased survival rates during initial RHDV
outbreaks and therefore likely promoted the establishment of
immunity in the populations which protected them against
subsequent outbreaks. It is feasible that this reduces the selective
pressure towards weaker binding HBGA phenotypes as a means to
avoid lethal RHDV infection. At present we cannot formally
exclude that the observed associations between low HBGA
binding and survival could be due to genetic drift rather than
from selection by the virus. Nevertheless, it is quite remarkable
that the observed associations occurred in a strain-specific pattern,
where in the French population affected by a G5 strain with
largely B-dependant binding a large increase in B- rabbit
frequency occurred. On the other hand, the G2 strain steadily
introduced in Australia is able to bind B as well as H type 2 with
no ability to bind A, therefore poorly recognizing rabbits with no B
expression and where A masks the otherwise available H type 2
(A+B2). Thus, the observed associations between survival or
genetic resistance and HBGA binding matched the strain
carbohydrate specificity. In addition, a prior study by Guillon et
al. showed an association between survival to another devastating
RHDV outbreak in France and a haplotype at the a1,2fucosyl-
transferases locus [35]. Although in the latter case the binding of
the responsible RHDV strain could not be analyzed, collectively
these analyses of wild animals indicate that RHDV outbreaks may
select animals depending on their HBGA binding characteristics in
a strain-dependent manner. Characterization of the binding
profile of two G2 strains showed that they did not bind to the A
antigen, unlike the five other RHDV strains tested. Since G2
strains appear to be the first pathogenic strains that circulated
when emergence of RHDV was observed, acquisition of A antigen
recognition by subsequent strains could have allowed a better
coverage of the ABH diversity and targeting of the less susceptible
and positively selected A+B2 animals. Collectively, the data
suggest that HBGA diversity tends to restrict the virus transmission
and therefore to protect the host population, which is in
accordance with the results of the models developed by Fouchet
et al. [44].
The initial observation that RHDV binds to HBGAs led to the
discovery that human noroviruses of the Norovirus genus (NoV),
which cause gastrointestinal infection commonly known as
‘‘winter-vomiting disease’’, also bind HBGAs [45,46,47,48]. Most
human norovirus strains bind a1,2-fucosylated HBGA structures
such as H type 1, Lewis b, Lewis y, A or B antigens (Fig 1), which
are expressed on epithelial cells and mucins of the gastrointestinal
tract and saliva of individuals of the secretor phenotype [49].
Secretor individuals possess a functional FUT2 gene (Fig 1A),
encoding an a1,2 fucosyltransferase expressed on many epithelial
cell types. Inactivating mutations of the FUT2 gene results in a
non-secretor phenotype where none of the above mentioned
structures are expressed on most epithelial cells [50]. Human
noroviruses cause a relatively mild, transient infection in healthy
individuals although they can be responsible for more severe
gastroenteritis in immunocompromised individuals, the elderly
and in young children, particularly in developing countries [51].
In human volunteer studies, strain-specific binding of HBGAs
correlated to infection and norovirus antibody detection [52,53].
Thus, nonsecretor individuals proved completely resistant to
infection by the Norwalk strain that binds to H type 1, Lewis b
and the A antigen. Moreover B-type individuals who are poorly
recognized by the strain were more likely to be either non-infected
or to remain asymptomatic. Likewise, analysis of outbreaks
showed a strong impact of either the secretor or the ABO
phenotypes on infection [54,55,56,57,58]. Analyses of the
carbohydrate specificity of many strains showed great variation
depending on the combined ABO and FUT2 polymorphisms.
Thus, each strain recognizes a subset of the population only,
although collectively NoVs can recognize all individuals except the
very small subgroup of nonsecretors/Lewis negative (FUT2-/
FUT3-) individuals who lack both the a2-linked fucose added by
the FUT2 enzyme and the a4-linked fucose added by the FUT3
enzyme [45,59,60]. These data indicate that HBGAs act as
attachment factors required for infection by noroviruses but also
that their polymorphism contributes to restriction of the
transmission of any given strain. Such a relationship between the
host and the pathogen diversity suggests co-evolutionary processes
Table 6. Correlation of A and B phenotypes of rabbits from
three populations in Australia with G2 strain binding
(percentages in parenthesis).
A and B expression
1 RHDV binding
2
Bendigo
3
Bacchus
Marsh
4 Hattah
5 Low Medium High
A+B+ 13 (59) 8 (35) 11 (61) 9 13 10
A2B2 7 (32) 14 (61) 1 (6) 3 8 11
A+B2 2 (9) 1 (4) 6 (33) 9 0 0
1p=0.0016.
2p=0.00011.
3No indication of genetic resistance to RHDV infection (Brian Cooke, personal
communication) and protection through RCV-A1 antibodies.
4Signs of genetic resistance to RHDV infection (Brian Cooke, personal
communication) and protection through RCV-A1 antibodies.
5Signs of genetic resistance to RHDV infection (Brian Cooke, personal
communication) and no protection through RCV-A1 antibodies.
doi:10.1371/journal.ppat.1002188.t006
Table 5. Correlation of B expression and RHDV binding of rabbits from Claira, not RHDV infected, and Canohe `s, RHDV survivors,
percentage in parenthesis.
Phenotype
1 RHDV binding
2
Populations A+B+ A+B2 A2B2 Low Medium High
Claira 18 (82) 1 (5) 3 (14) 6 (27) 10 (45) 6 (27)
Canohe `s 0 2 (40) 3 (60) 5 (100) 0 0
1p=0.002, Fischer’s exact test for B+ versus B2 phenotype.
2p=0.019, Fischer’s exact test.
doi:10.1371/journal.ppat.1002188.t005
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blood group antigens polymorphism is maintained in human
populations for reasons that are still unclear. Nevertheless, it has
been shown that the ABO and FUT2 genes are under balancing
frequency-dependent selection [61,62,63,64,65]. In addition, the
FUT2 gene has been subjected to intense gene conversion with its
paralogues FUT1 and Sec1during mammalian evolution [66]. In
various species, including humans, many primate species, rat,
mouse, and pig Sec1 is a pseudogene. Yet, some of the alleles
encode weakly functional enzymes in rabbits [35]. The ABO gene
family underwent a birth-and-death mode [67] of evolution during
vertebrate evolution [4]. These elements strongly suggest that
through their polymorphism HBGAs are involved in interactions
with environmental factors, most likely pathogens and the present
observations strongly support of this view.
In conclusion, our work showed that similar to human
noroviruses and despite a lower genetic diversity, RHDV strains
bind to carbohydrates of the HBGA family with distinct
specificities allowing them to preferentially recognize some
subgroups of the host population. Due to variable cross-
recognition of the available carbohydrate epitopes, strain binding
patterns do not fit precisely with the ABH phenotypes of individual
animals, generating complex patterns of recognition within
populations. These carbohydrates act as attachment factors that
facilitate infection, or at least symptomatic expression of the
disease. Survivors to outbreaks are selected among animals
showing the lowest binding and most protected from lethal
disease. The polymorphism of ABH expression would thus act to
generate genetic resistance to RHDV at the population level.
Material and Methods
Ethic statement
Work involving the acquisition and sampling of French wild
rabbits was carried out in strict accordance with the bylaw (Arre ˆte ´
Nu 2009-014) issued by the Paris Prefecture. The acquisition and
sampling of Australian wild rabbits was carried out in strict
accordance with the guidelines of the Australian Code of Practice
for the Care and Use of Animals for Scientific Purposes. All
procedures were approved by the Commonwealth Scientific and
Industrial Research Organisation (CSIRO) Sustainable Ecosystems
Animal Ethics Committee (Licence # SEAEC 06-31). Rabbits were
caught alive in cage traps or with ferrets. The cages were set on or
around active rabbit warrens and baited with diced carrots. When
ferrets were used, warren entrances were covered with purse nets
and a ferret was released into the warren to flush out the rabbits.
Caught animals were killed by cervical dislocation. The challenge
study performed on laboratory animals was carried out in strict
accordance with the recommendations of the French National
Guide for the Ethics of Animal Experiments. The protocol was
approved (Permit Number: 10/03/09-05B) by the ethics committee
‘‘ComEth Anses/ENVA/UPEC’’ registered under number 16 to
the National Committee of Ethics on Animal Experiments of the
Ministry of Higher Education and Research. All efforts were made
to minimize suffering (observation of animals twice a day,
euthanasia of animals showing signs of suffering) and euthanasia
was performed under xylacine and ketamine anesthesia.
Rabbit duodenum sampling
Rabbit duodenums were collected from either domestic New
Zealand White rabbits, from 22 wild rabbits of a dense population
in Claira, France and from 15 wild rabbits from small populations,
including Canohe `s, with previously documented RHDV infection
in the area of Perpignan, France, not far from the Spanish border
and from 63 animals from 3 populations in Australia. The first
5 cm posterior to the gastroduodenal junction was removed after
clearing the section from intestinal contents, the sample was
vigorously rinsed in phosphate buffered saline (PBS) and stored in
RNAlater (Sigma-Aldrich, St. Louis, MO). Sections of the
duodenum were then rinsed in PBS, opened and scraped into
RTL lysis buffer (Qiagen, Hilden, Germany) containing b-
mercaptoethanol. The tissue scrapings were homogenized and
split into three parts for ELISA assays, RNA and DNA extraction.
The ELISA scrapings were boiled for 10 minutes.
Duodenum phenotyping ELISA
Rabbit duodenum scrapings were phenotyped using ELISA.
Briefly, the duodenum scrapings were diluted in duplicates in
eleven two-fold dilutions with final dilutions ranging from 1/100
to 1/102,400 in 0.1 M sodium carbonate buffer pH 9.5 on a
maxisorb plate (ThermoFischer scientific, Waltham, MA). Anti-
body dependent assays were blocked with 5% non-fat dry milk
(Re ´gilait, Saint-Martin-Belle-Roche, France) diluted in PBS while
lectin assays were blocked with synblock (AbD serotec, Oxford
UK). A antigen was detected using mouse monoclonal anti-A
antibodies, 2A12, 2A21, and 2A15, all previously characterized to
specifically bind A antigen based on all types of precursor
structures [68]. B antigen was detected using a specific mouse
monoclonal B49, a B-specific broadly reacting antibody [69]. H
type 2 (Le
y) expression was determined using HRP conjugated
Ulex europaeus-I (Sigma-Aldrich, St. Louis, MO). Secondary horse
radish peroxidase (HRP) conjugated anti-mouse (Uptima/Inter-
chim, Montlucon FR) was used for A antigen detection and a
biotin conjugated anti-mouse (vector laboratories, Burlingame,
CA) followed by HRP conjugated avidin (vector laboratories,
Burlingame, CA) for B detection due to relatively low amounts of
B antigen in rabbit tissues. TMB (BD Bioscience, San Jose CA)
was used as a substrate for all assays and O.D. values were
measured at 450 nm.
RHDV preparation
RHDV was prepared from infected rabbit livers. Livers were
cut into small pieces and homogenized with PBS at 0.25 g/mL.
Liver/PBS mixtures were centrifuged 20 minutes to remove
cellular debris. RNA was isolated from 200 mL of each liver
preparation with the RNeasy mini kit (Qiagen, Hilden, Germany)
according to manufacturer’s instructions and 5 mL of isolated
RNA was reverse transcribed from each liver. RNA was reverse
transcribed with random primers and Superscript II reverse
transcriptase (Invitrogen, Carlsbad CA) according to instructions
for first-strand cDNA synthesis. 2 mL cDNA/well was further
analyzed in real-time PCR with primers and probes designed
according to Taqman chemistry, forward primer: 59 TCTGTC-
GTCAGGCGCACC 39, reverse primer: 59 GACGAGTAG-
TTGTTGAGCGAAAG 39 and probe: 59 FAM-CAGTACGG-
CACAGGCTCCCAACCA-TAMRA 39. A plasmid containing
the amplicon was used as a standard of 4 different concentrations
for each run on an Mx3005P (Agilent technologies, Santa Clara
CA). All real-time PCR tests were run in triplicates and together
with several previously quantified RHDV strain cDNA. In all
further assays RHDV from each strain was used in similar
concentrations.
RHDV binding assay
RHDV binding to rabbit duodenum scrapings was analyzed in
the same manner as the duodenum phenotype ELISA. Here
rabbit duodenum scrapings were diluted in a range of 11 dilutions
and coated in 0.1 M sodium carbonate buffer. Plates were blocked
RHDV Strain and Host-Dependent Glycan Interactions
PLoS Pathogens | www.plospathogens.org 17 August 2011 | Volume 7 | Issue 8 | e1002188with 5% non-fat dry milk diluted in PBS or distillated water.
RHDV from six strains belonging to genetic groups G1 to G6
(Fig 2) was prepared from infected livers as described above. High
titered rabbit sera Lp4 or an RHDV monoclonal antibody 2G3
was used for G1–G5 and G6 detection, respectively. Secondary
antibodies anti-rabbit conjugated with HRP were used against Lp4
and anti-mouse biotin followed by avidin-HRP was used for
RHDV detection with 2G3 anti-RHDVa (G6) monoclonal
antibody [70]. Addition of substrate and measurement of the
plates were performed as described above.
RHDV binding to synthetic sugars was tested by screening a
panel of PAA-conjugated and BSA-conjugated sugars (Table S1).
1 mg of synthetic sugars were coated. For the first screening a high
concentration of RHDV was used. For the detailed analysis of
binding to the positive synthetic sugars a range of dilutions was
used. RHDV binding ELISA was performed as described above.
RHDV binding step was performed at 4uC for PAA-conjugated
sugars and at 37uC for BSA-conjugated sugars, though no major
difference was visible at the alternate temperatures.
Statistical calculations for ABH phenotyping and RHDV
binding
A threshold was set at 3 times the background for each
phenotype or RHDV binding assay and dilution value of each
sample for crossing the threshold were analyzed. All values were
normalized against values obtained with the mannose-binding
lectin Concavalin A to control for differences in the amount of
material scraped, as protein quantification proved to be difficult
due to the addition of b-mercaptoethanol to remove any potential
anti-RHDV antibodies in the duodenum that would interfere with
the analysis. Different sets of rabbits regarding ABH phenotypes
and RHDV binding were analyzed with a chi-squared test or
Fischer’s exact test.
RHDV agglutination
Blood from A, B and O individuals was washed 3 times in PBS
and diluted to 2% RBC. RBC were added to virus dilutions in V-
shaped wells, 1610
9 genomic copies of virus was used as
determined through real time RT-PCR, described above.
Agglutination titers were determined after 3 h incubation at room
temperature.
Immunohistochemistry
Tissue sections of nine French wild-rabbit duodenums, liver and
trachea were de-parafinated through baths in LMR and ethanol.
Endogenous peroxidase activity was blocked with 0.3% hydrogen
peroxide. Non-specific binding was blocked with 5% goat serum in
PBS. HRP conjugated Ulex europaeus-I (Sigma-Aldrich, St. Louis,
Figure 10. Summary of the RHDV strains specificities for ABH antigens. The size of the A, B and H letters represents the level of expression
in the rabbit duodenum and the volume and color intensities of the ovals correspond to the ability of each strain to recognize the epitopes. The
strains shown above the ABH antigens (G2–G5) serially replaced each other in France (G2: 1988–1990; G3: 1990–1997; G4: 1993–1999; G5: 1994–2009),
whereas those shown below evolved independently.
doi:10.1371/journal.ppat.1002188.g010
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monoclonal antibody B49 were used for binding to H type 2, A
and B phenotyping respectively. A rabbit expressing both A and B
antigens was used for RHDV binding. All 6 strains described
above were used at 2610
9 genome copies/ml (see RHDV
preparation) and detected with the mouse monoclonal anti-
RHDV antibody 2G3 [70]. Dilutions of lectin, antibodies and
virus were done in 1% BSA in PBS and binding at 4uC overnight.
A biotinylated anti-mouse antibody (vector laboratories, Burlin-
game, CA) diluted in 1% BSA in PBS was bound to all of the
assays with primary mouse antibodies. Binding of the biotinylated
anti-mouse antibody was followed up with HRP-conjugated avidin
vector laboratories, Burlingame, CA) also this diluted in 1% BSA
in PBS. Substrate was added to the slides (AEC kit, vector
laboratories, Burlingame, CA) followed by Mayer’s hemalum
solution (Merck, Whitehouse Station, NJ) for contrast staining.
Release of glycans and mass spectrometry analysis
Tissue homogenization and protein extraction. 10
samples of rabbit duodenum were analyzed through a procedure
previously described [71]. Briefly, tissues were first weighed and
then were disrupted on ice by using a homogenizer in the presence
of 1 mL degassed homogenization buffer (0.6 M Tris, 150 mM
NaCl, 5 mM EDTA and 1% CHAPS at pH 8.5). Lysates were
then dialyzed against 50 mM ammonium bicarbonate (Ambic;
Sigma-Aldrich, UK) buffer, pH 8.5, at 4uC for 48 h with several
buffer changes. This was followed by lyophilization of the tissue
lysates.
Protein reduction and carboxymethylation. Proteins were
reduced and carboxymethylated as described previously [72].
Briefly, lyophilized tissue lysates were reduced at 37uC for 1 h in
50 mM Tris-HCl buffer, pH 8.5, containing 10 mg/ml dithio-
threitol (Roche, UK). Carboxymethylation was carried out by the
addition of 0.6 M Tris (Sigma-Aldrich, UK) buffer containing
12 mg/mL of iodoacetic acid (Sigma-Aldrich, UK) at room
temperature in the dark for 1.5 h. After carboxymethylation,
samples were dialyzed against 50 mM ammonium bicarbonate,
pH 8.5, at 4uC for 48 h with several buffer changes, and
subsequently lyophilized.
Cleavage into peptides and glycopeptides. Protein dig-
estion using TPCK-treated, bovine pancreas trypsin (EC 3.4.21.4,
Sigma-Aldrich, UK) and purification was performed as described
previously [73]. For each microgram of tissue sample, 1.2 mgo ft r y p s i n
from a trypsin solution in 50 mM ambic buffer (pH 8.4) was added to
the lysates and was incubated at 37uC for 14 h, followed by
purification with Oasis HLB extraction cartridges (Waters, UK).
The cartridges were successively conditioned with 5 mL of methanol,
5 mL of 5% (v/v) acetic acid, 5 mL of propan-1-ol and 15 mL of 5%
(v/v) acetic acid. The digested samples were then loaded onto the
cartridges, washed with 20 mL of acetic acid (5% v/v) to remove
hydrophilic contaminants, and then eluted sequentially with 5 mL of
each 20% and 40% propan-1-ol solution in 5% (v/v) acetic acid. The
propan-1-ol elutions, which contain glycopeptides and peptides, were
concentrated with the Savant SpeedVac (Thermo Fisher Scientific,
UK), combined and subsequently lyophilized overnight.
Digestion of N-glycans from glycopeptides. The lyophi-
lized glycopeptide and peptide fractions were dissolved in 200 mL
of 50 mM ambic buffer (pH 8.4) before adding in a total of 5 U of
PNGase F (EC 3.5.1.52, Roche) and incubate at 37uC for 20–
24 h. The samples were then lyophilized overnight and re-
dissolved in 200 mL of 5% (v/v) acetic acid for solid-phase
extraction with Sep-Pak C18 cartridges (Waters, UK) as described
for the tryptic digested lysates. The acetic acid fractions, which
contained the released N-glycans, were lyophilized and later
permethylated. The propan-1-ol eluents, which contain O-
glycopeptides, were combined prior to lyophilisation.
Release of O-glycans from glycopeptides. Reductive
elimination of O-glycans was performed as explained previously
[73]. Four hundred microliters of 0.1 M potassium hydroxide
(Sigma-Aldrich, UK) containing potassium borohydride (54 mg/
mL) (Sigma-Aldrich, UK) was added to dried samples and
incubated at 45uC for 14–16 h. The reaction was terminated by
adding a few drops of 5% (v/v) acetic acid followed by purification
with Dowex 1-X8 desalting column (Sigma-Aldrich, UK). The
columnswerefirstwashedwith15 mLof5%(v/v)aceticacid.Next,
the samples were loaded and eluted with 5 mL of 5% (v/v) acetic
acid. The volume of the eluents was reduced with Savant SpeedVac
followed by overnight lyophilization. Excess borates in the samples
were removed by co-evaporating with 10% (v/v) acetic acid in
methanol under a stream of nitrogen at room temperature. The
purified native O-glycans were subsequently permethylated.
Chemical derivatization of N and O-glycans. Sodium
hydroxide (NaOH) permethylation was performed according to an
established procedure as described previously [74]. Briefly, 5–7
NaOH pellets (Sigma-Aldrich, UK) were ground to fine powder
and mixed with 2–3 mL anhydrous dimethyl sulfoxide (Romil,
UK) before adding to each dried sample. This was followed by the
addition of 0.5–0.7 mL of methyl iodide (Alfa Aeser, UK) and
vigorous shaking at room temperature for 15 min. Permethylated
glycans were extracted with chloroform and then purified by using
Sep-Pak C18 cartridges. The cartridges were successively
conditioned with methanol (5 mL), water (5 mL), acetonitrile
(5 mL) and water (15 mL). Each sample was dissolved in 200 mL
of methanol:water (1:1) solution before loading onto the cartridges.
The cartridges were washed with 5 mL of water and then eluted
sequentially with 3 mL of each 15, 35 and 50% acenotrile solution
in water. All eluents were then concentrated with a Savant
SpeedVac and subsequently lyophilized.
MS and MS/MS analyses of permethylated glycans.
MALDI-TOF data were acquired on a Voyager-DE STR mass
spectrometer (Applied Biosystems, Foster City, CA) in the reflectron
mode with delayed extraction. Permethylated samples were
dissolved in 10 mL of methanol, and 1 mL of dissolved sample was
premixedwith1 mLofmatrix(20 mg/ml2,5-dihydroxybenzoicacid
in 70% (v/v) aqueous methanol), spotted onto a target plate, and
dried under vacuum. Further MS/MS analyses of peaks observed in
the MS spectra were carried out using a 4800 MALDI-TOF/TOF
(Applied Biosystems) mass spectrometer in positive ion mode (M +
Na)+. The collision energy was set to 1 kV, and argon was used as
collisiongas.Samplesweredissolvedin10 mL of methanol, and 1 mL
was mixed at a 1:1 ratio (v/v) with 2,5-dihydroxybenzoic acid
(20 mg/mL in 70% methanol in water) as matrix.
Analyses of MALDI data. The MS and MS/MS data were
processed using Data Explorer 4.9 Software (Applied Biosystems,
U.K.). The mass spectra were baseline corrected (default settings)
and noise filtered (with correction factor of 0.7), and then
converted to ASCII format. The processed spectra were then
subjected to manual assignment and annotation with the aid of a
glycobioinformatics tool known as GlycoWorkBench [75]. Peak
picking was done manually, and proposed assignments for the
selected peaks were based on molecular mass composition of the
12C isotope together with knowledge of the biosynthetic pathways.
Some of the proposed structures were then confirmed by data
obtained from MS/MS experiment.
Rabbit challenge
31 New Zealand white rabbits of 12 weeks were grouped into
three groups of 10 or 11 rabbits and placed in 3 rooms (2 cages
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filtered air according to biosafety and bioethical procedures. The
experimental study was performed under the authorization of
animal experimentation number 10/03/09-05B delivered by the
ethics committee ComEth Anses/ENVA/UPEC. Six rabbits were
sampled for pre-challenged serum just prior to infection. The
rabbits were orally infected with 10
5,1 0
7 or 10
9 genome copies of
the G4 virus 95–10 [17] in a total of 1 mL PBS. At the time of
infection the rabbits were 12 weeks of age. As rabbits succumbed
to infection, post-mortem examinations were realized and liver
and duodenum were sampled in RNAlater (Sigma-Aldrich, St.
Louis, MO). Surviving animals were killed humanely after 11 days,
examined for macroscopic lesions, and tissue samples were
collected. Liver and duodenum scrapings were analyzed for
RHDV quantification as described above. Duodenum was also
phenotyped for ABH expression as described above and tested for
G4 binding, also described above.
Accession numbers
Fut2 XM_00273737
Sec1 X80225
Fut1 NM_001082403
G1 JF438967
G2 FR823355
G3 FR823354
G4 AJ535094
G5 AM085133
G6 AJ969628
Supporting Information
Figure S1 MALDI-TOF MS of N-glycans released by
PNGase F digestion from three of the Rabbit Duodenum
samples analyzed. Glycan were permethylated prior to
MALDI-TOF analysis. Structures were assigned taking into
account the molecular weight and the biosynthetic pathway. A
structure containing monosaccharides outside a bracket suggests
potential structural heterogeneity of the peak. ‘‘X’’ indicates peaks
corresponding to high mannose N-glycans. A: Profile of
permethylated N-glycans released from rabbit duodenum, Sample
2. B: Profile of permethylated N-glycans released from rabbit
duodenum, Sample 4. C: Profile of permethylated N-glycans
released from rabbit duodenum, Sample 6.
(PDF)
Figure S2 Representative MALDI-TOF-TOF mass spec-
tra of O-glycans released from three of the Rabbit
Duodenum samples analysed (Samples 2, 4, 6). Glycans
released by b-elimination reaction were permethylated prior to
MALDI-TOF-TOF analysis. The fragment ions are consistent
with the sequences shown in the inset. A: MS/MS spectrum of the
molecular ion at m/z 708, sample 2; B: MS/MS spectrum of the
molecular ion at m/z 953, sample 2; C: MS/MS spectrum of the
molecular ion at m/z 1128, sample 2; D: MS/MS spectrum of the
molecular ion at m/z 1199, sample 2; E: MS/MS spectrum of the
molecular ion at m/z 1332, sample 2; F: MS/MS spectrum of the
molecular ion at m/z 1404, sample 2; G: MS/MS spectrum of the
molecular ion at m/z 1578, sample 2; H: MS/MS spectrum of the
molecular ion at m/z 708, sample 4; I: MS/MS spectrum of the
molecular ion at m/z 912, sample 4; J: MS/MS spectrum of the
molecular ion at m/z 954, sample 4; K: MS/MS spectrum of the
molecular ion at m/z 1199, sample 4; L: MS/MS spectrum of the
molecular ion at m/z 1373, sample 4; M: MS/MS spectrum of the
molecular ion at m/z 708, sample 6; N: MS/MS spectrum of the
molecular ion at m/z 912, sample 6; O: MS/MS spectrum of the
molecular ion at m/z 953, sample 6; P: MS/MS spectrum of the
molecular ion at m/z 1128, sample 6; Q: MS/MS spectrum of the
molecular ion at m/z 1158, sample 6; R: MS/MS spectrum of the
molecular ion at m/z 1199, sample 6; S: MS/MS spectrum of the
molecular ion at m/z 1331, sample 6; T: MS/MS spectrum of the
molecular ion at m/z 1373, sample 6.
(PDF)
Figure S3 MALDI-Ion Trap-TOF MS, MS/MS and MS
3
mass spectra of O-glycans released from the Rabbit
Duodenum Sample 4. The sample was kindly analyzed by
Shimadzu Ltd, by their MALDI-Ion Trap-TOF instrument
‘‘Axima Resonance’’. A: MS spectrum of sample 4. The
annotation of the structure at m/z 1373 takes into account the
information emerging from fragmentation data obtained through
MS/MS and MS
3 analysis. B: MS/MS spectrum of peak at m/z
1373. Theoretical fragments, shown at the top- right corner of the
figure, match the observed ones obtained by Ion trap-MS/MS
analysis, reported on the annotated peaks. Peaks marked with the
symbol ‘‘X’’ are due to the matrix used for MALDI analysis. C:
MS
3 spectra of the ion at m/z 1079 obtained after fragmentation
of the parent ion at m/z 1373. Theoretical fragments, shown at
the top- right corner of the figure, match the observed fragments
obtained by Ion trap-MS
3 fragmentation, reported on the
annotated peaks. Peaks marked with the symbol ‘‘X’’ are due to
the matrix used for MALDI analysis.
(PDF)
Figure S4 RHDV challenge of A+B+ and A2B2 rabbits.
31 rabbits were infected with an A and B binding G4
strain at 10
7 or 10
9 virus copies. Rabbits either succumbed to
infection or were sacrificed after 11 days. Duodenum and liver
samples were collected at time of death. Duodenum was
phenotyped for G4 binding. Duodenum and liver were also
assayed for virus RNA via real time RT-PCR. (A–B) Virus RNA of
liver or duodenum for 10
7 infectious dose, (C–D) virus RNA of
liver or duodenum for 10
9 infectious dose, where A+B+ (circle),
A2B2 (triangle), dead rabbits (black symbol) and survival rabbits
(white symbol).
(PDF)
Figure S5 Survival analysis of rabbits challenged with
the G4 strain at 3 genome copies doses (10
5,1 0
7 and 10
9).
At 11 days, all survivors were sacrificed. There were no statistically
significant differences between the 3 groups.
(PDF)
Table S1 Neoglycoconjugates used to determine the
carbohydrate binding characteristics of RHDV strains.
aOligosaccharides were used coupled to either polyacrylamide via
an 3 carbon spacer (R1), or to human serum albumin via either a
p-aminophenylethyl spacer (R2) or an acetyl phenylenediamine
spacer (R3).
(PDF)
Table S2 Contingency table of relationship between
expression of H type 2 with A or B.
1p=4.8610
27;
2p=7.5610
26 ;
3p=2.0610
29.
(PDF)
Table S3 Summary of all structures observed in the
MALDI-TOF-MS spectra of the duodenum tissue from
rabbits, Samples 1–10. The symbol presentation of O-glycans
is based on the nomenclature used in Essentials of Glycobiology
textbook (http://www.ncbi.nlm.nih.gov/books/NBK1908) and
adopted by the Consortium for Functional Glycomics (http://
www.functionalglycomics.org). Mass values [M + Na]+, cartoon
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peak detected. Intensity of the peaks observed is reported for each
sample analyzed. ND = not detected – = very minor component
(,25%); - = minor component (25–50%); + = major component
(.25%); ++ = very major component (25–50%); +++ = most
abundant component (.50%).
(PDF)
Table S4 Composition of permethylated O-glycans in
10 samples of Rabbit Duodenum, obtained through
MALDI-TOF analysis.
(PDF)
Table S5 Significance of correlation between RHDV
binding and ABH phenotypes with Fischer’s exact test.
1 7 rabbits A+B-H2 and one A+B-H+ with weak H type 2
expression.
(PDF)
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